After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Vanda Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vanda Pharmaceuticals Inc is $280.50M. A total of 0.7 million shares were traded on the day, compared to an average of 667.08K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, VNDA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for 4.71 per share on Mar 03 ’25. After the transaction, the President and CEO now owns 2,275,731 company shares. In a previous transaction on Feb 28 ’25, Polymeropoulos Mihael Hristos bought 10,000 shares at 4.76 per share. VNDA shares that President and CEO owns now total 2,361,730.
Among the insiders who bought shares, Polymeropoulos Mihael Hristos acquired of 10,000 shares on Feb 27 ’25 at a per-share price of $4.76. This resulted in the President and CEO holding 2,351,730 shares of VNDA after the transaction. In another insider transaction, Polymeropoulos Mihael Hristos bought 10,000 shares at $4.76 per share on Feb 26 ’25. Company shares held by the President and CEO now total 2,341,730.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for VNDA in the last 3 months, the mean price target is $12.67 with high estimates of $20.00 and low estimates of $5.00. In terms of 52-week highs and lows, VNDA has a high of $6.75 and a low of $3.71.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.24, while its Total Shareholder’s Equity was $504.93M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 4.33.
